AG and all,
Here's today's chart.
quote.yahoo.com
Looks like today's news held up reasonably well, starting up, coming back, and ultimately only ending up down a little bit....a sign that maybe the big drops on the news aren't quite as big and the support is higher. Looks like the cartilage is well on the way toward the human trial, likely starting later this year. This patent is an extremely important one for the long term.
Otherwise, it is likely we will see the qtrly. announced very soon, and it will likely be a pleasant surprise imo. Also, of importance, is that the Third International meeting of the Global Diabetic Foot Ulcer Study group, held recently in Europe, I am told was a great success for both ATIS and the ATIS/S&N joint venture. The leading scientists involved were very positive on Dermagraft and ATIS/S&N. We shall see.
It will be interesting to continue to follow the price in the near term, not to mention the next six months.
Regards,
Marshall
|
